Matthew M Grabowski

7PUBLICATIONS
44CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical mycologyChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 11, 2025
The Importance of Integrating Surgical Resection into Preclinical Glioblastoma Modeling.

Josephine Volovetz, Line V Buchwald, Karina Straede

|Jun 28, 2023
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.

Juyeun Lee, Michael Nicosia, Ellen S Hong

|Sep 20, 2022
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.

Defne Bayik, Cynthia F Bartels, Katreya Lovrenert

|Feb 05, 2021
Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome.

Balint Otvos, Tyler J Alban, Matthew M Grabowski

|Jul 17, 2020
The intersection between immunotherapy and laser interstitial thermal therapy: a multipronged future of neuro-oncology.

Ethan S Srinivasan, Eric W Sankey, Matthew M Grabowski

|Apr 18, 2020
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner.

Defne Bayik, Yadi Zhou, Chihyun Park

Pageof 2